At ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that longevity is a priority.

Basecamp Research will train AI models on the world’s largest biological dataset and design new medicines. Most AI ...

Aging Research and Drug Discovery meeting opened with a pitch for prevention and a program building the endpoints the field needs.

Younger founder Christin Glorioso on turning a six-month competition into a side-by-side trial of aging clocks.

Postgraduate program aims to turn geroscience, biomarkers and emerging technologies into evidence-based healthspan medicine for physicians.

Allergan Aesthetics is pairing new hallmarks-of-aging science with real skin data from people on weight-loss drugs.

Regenerative platforms reach patients on a different clock – our new report explains why, with MuseCell Innovations clearest case in point.

LW-1017, an oral drug that switches the brain’s cleanup system back on, reduced Parkinson’s and Alzheimer’s pathology in aged ...

Amorepacific deal puts therapeutic target discovery to work on skin aging – and Junevity sees scope for an ‘Ozempic moment’.

A further $173 billion a year is real on paper – but only once three separate regulatory clocks finish running down.

Resolution Therapeutics has treated its last EMERALD trial patient, putting macrophage-based therapy on track for results ...